Check the RBI Grade B Exam Analysis 2025 for 18 October covering difficulty level, good attempts, and section-wise review of ...

Estimated costs for the first phase of the marina project, including work on marina buildings and docks, could cost about $26 ...

PIK3CA mutant cohort of the Phase 3 VIKTORIA-1 clinical trial is fully enrolledAdditional analysis of data from a Phase 1b clinical trial that included all patients treated with gedatolisib combined ...

Alphamab Oncology (Stock Code: 9966.HK) announced that the first interim analysis results of a phase III clinical trial of anbenitamab injection (KN026), independently developed by the Company and ...

With the swift rise of period tracking apps and more research into how hormones impact energy levels and performance, Helen ...

Moderna, Inc. remains under pressure in 2025, despite recent next-gen COVID vaccine approval & cancer vaccine trial. Learn ...

UEFA Technical Observer Joe Montemurro highlights Manchester United's defensive mettle in their Matchday 2 victory over ...

With world leaders set to gather in Brazil for COP30 in November, new analysis from an international team of climate policy ...

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced several important updates across its development program for povetacicept (pove), an investigational recombinant fusion protein ...

The 2025 ESMO annual meeting featured a urothelial carcinoma proffered paper session and a presentation by Dr. Maria De ...

Advances in mass spectrometry and chromatography are enhancing pesticide residue analysis, focusing on exposomics and risk assessment for improved food safety. Ion chromatography is evolving with new ...

After 5 years, Kisqali® plus endocrine therapy consistently shows significant and clinically meaningful benefit in invasive disease-free survival1 Kisqali remains the only CDK4/6 inhibitor ...